Mirum Pharmaceuticals (MIRM) Goodwill & Intangibles (2021 - 2026)

Mirum Pharmaceuticals has reported Goodwill & Intangibles for 6 years, with the latest figure at $254.2 million in Q1 2026.

• For the quarter ending Q1 2026, Goodwill & Intangibles rose 4.23% year-over-year to $254.2 million; the trailing twelve-month figure through Mar 2026 stood at $254.2 million (up 4.23% YoY), and the FY2025 full-year result was $260.9 million, up 4.44% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $254.2 million, down from $260.9 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $261.8 million in Q2 2024, with the low at $18.5 million in Q1 2022.
• Average Goodwill & Intangibles over 5 years is $179.3 million, with a median of $243.8 million recorded in 2025.
• Year-over-year, Goodwill & Intangibles soared 473.68% in 2023 and fell 9.34% in 2025.
• Tracing MIRM's Goodwill & Intangibles over 5 years: stood at $59.0 million in 2022, then soared by 329.02% to $252.9 million in 2023, then fell by 1.23% to $249.8 million in 2024, then grew by 4.44% to $260.9 million in 2025, then declined by 2.59% to $254.2 million in 2026.
• The last three Goodwill & Intangibles figures came in at $254.2 million (Q1 2026), $260.9 million (Q4 2025), and $231.9 million (Q3 2025), per Business Quant data.

Peer Comparison